San Francisco, CA, United States of America

Dylan L Daniel

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Dylan L. Daniel

Introduction: Dylan L. Daniel, based in San Francisco, CA, is an accomplished inventor with a remarkable portfolio of seven patents. His work focuses primarily on biopharmaceutical innovations that aim to provide groundbreaking solutions in cancer treatment and immune response modulation.

Latest Patents: Among his latest patents, the "Activatable Cytokine Constructs and Related Compositions and Methods" presents a novel dual monomer construct that enhances the efficiency of cytokine proteins through the inclusion of cleavable moieties and dimerization domains. This innovation allows for better control of cytokine activity, potentially leading to improved therapeutic outcomes in various medical settings. Another significant patent is the "CKIT Antibody Drug Conjugates," which involves the development of anti-c-KIT antibodies and their conjugates aimed at treating cancers by selectively targeting and delivering drugs to cancer cells.

Career Highlights: Dylan's expertise has been honed through his tenure at leading pharmaceutical companies such as Novartis AG and CytomX Therapeutics, Inc. These organizations have provided him with the platform to contribute to significant advancements in the field of therapeutics, particularly in designing molecules aimed at combating complex diseases like cancer.

Collaborations: Throughout his career, Dylan has collaborated with remarkable talents, including Sayantan Mitra and Nicole G. Lapuyade. Their combined efforts have undoubtedly propelled their research initiatives, emphasizing the importance of teamwork in the realm of innovation and discovery.

Conclusion: Dylan L. Daniel stands out as a prominent inventor whose contributions through his patents are setting new standards in biopharmaceutical developments. His innovative approaches to cytokine constructs and antibody drug conjugates not only reflect his deep understanding of the science but also his commitment to enhancing patient outcomes in cancer treatments. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…